Huntington National Bank
PCVX icon

Huntington National Bank’s Vaxcyte PCVX Stock Holding History

Huntington National Bank’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4K Hold
369
– – ﹤0.01% 1738
2026
Q1 		$21.4K Hold
369
– – ﹤0.01% 1624
2025
Q4 		$17K Hold
369
– – ﹤0.01% 1632
2025
Q3 		$13.3K Buy
369
+217
+143% +$7.19K ﹤0.01% 1740
2025
Q2 		$4.94K Sell
152
-16
-10% -$525 ﹤0.01% 2008
2025
Q1 		$6.34K Buy
168
+16
+11% +$1.28K ﹤0.01% 1907
2024
Q4 		$12.4K Buy
152
+5
+3% +$496 ﹤0.01% 1697
2024
Q3 		$16.8K Buy
147
+124
+539% +$11.2K ﹤0.01% 1568
2024
Q2 		$1.74K Buy
23
+18
+360% +$1.23K ﹤0.01% 2192
2024
Q1 		$342 Buy
+5
New +$346 ﹤0.01% 2386
2023
Q4 		– Sell
-18
Closed -$918 – 3934
2023
Q3 		$918 Buy
+18
New +$888 ﹤0.01% 2222

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Huntington National Bank's PCVX Position: Q2 2026 in Review

Huntington National Bank held its Vaxcyte (PCVX) position steady in Q2 2026 at 369 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1738.

Huntington National Bank first reported a position in PCVX in Q3 2023 and has held it in 11 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Huntington National Bank held 369 shares of Vaxcyte worth $21.4K as of Q2 2026.
  • Huntington National Bank left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1738 holding.
  • Huntington National Bank first reported a position in Vaxcyte in Q3 2023 and has held it in 11 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.